3647 results for «645»
3647 results
Coronary artery disease: more imaging, less imagination
18 May 2023 – From EuroPCR 2023
In these slides, explore associations between angiography-based FFR and OCT-detected luminal obstruction, prognostic impact of ischaemia vs. plaque vulnerability, CT's mortality foresight, and much more.
TAVI 1: durability, mismatch and challenging anatomy
18 May 2023 – From EuroPCR 2023
Explore TAVI longevity: Five-year Portico valve outcomes, bioprosthetic dysfunction post-surgery or self-expanding TAVI, prosthesis-patient mismatch impact, and innovative valve-in-valve TAVI insights, and more.
ACS - Abstract session
19 May 2023 – From EuroPCR 2023
Looking for a quick review of the Abstract session on acute coronary syndrome (ACS)? Explore the presentation slides available here and catch up on key elements to consider.
TAVI 2: new devices, procedural refinements
19 May 2023 – From EuroPCR 2023
Seeking a recap of the TAVI Abstract session? Dive into the provided slides containing the main points of the presentation.
Large-bore mechanical thrombectomy vs catheter-directed thrombolysis for treatment of intermediate-risk pulmonary embolism: primary outcomes from the PEERLESS randomized controlled trial
30 Oct 2024
Elad Asher provides his take on the PEERLESS trial presented by Wissam A. Jaber at TCT 2024 in Washington.
Author
How to close vascular access with a combined suture-/plug-based strategy using one ProStyle and one Angio-Seal in TAVI
29 Jan 2026
Large-bore femoral access closure remains a critical step in transfemoral TAVI, where access-site complications can significantly impact outcomes.
This My Toolkit article presents a step-by-step tutorial on a combined suture- and plug-based closure strategy using one ProStyle™ and one Angio-Seal®. The technique aims to achieve rapid, reliable...
Author
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
